OraSure Technologies (OSUR) Q3 2026 earnings summary

Executive summary

• Q3 revenue rose 14% YoY to $30.9M as operational efficiencies supported higher margins and continued return-to-growth execution.

• Strategy focuses on differentiated point-of-need diagnostics, portfolio expansion, localized capabilities and partnerships; 2027 revenue growth is expected to accelerate from 2026.

Financial highlights

• Q3 revenue was $30.9M, up 14% YoY and 1% sequentially; 9M revenue rose 1% to $89.5M.

• Q3 GAAP gross profit was $14.0M versus $11.8M; GAAP gross margin was 45.2% versus 43.5%, and non-GAAP gross margin was 45.9% versus 44.2%.

• Q3 GAAP operating loss narrowed to $13.0M from $16.1M; non-GAAP operating loss was $10.2M versus $12.7M. G&A fell $2.4M to $12.0M.

• Q3 GAAP net loss was $13.1M versus $13.7M; non-GAAP net loss was $10.1M versus $9.8M. GAAP diluted loss per share was $0.19, unchanged YoY.

• 9M net loss improved to $29.2M from $49.4M, including a $22.5M noncash contingent-consideration benefit.

Outlook and guidance

• Q4 revenue guidance is $30M-$32M; FY 2026 guidance is $119.5M-$121.5M, implying 3.8%-5.6% growth and 4.7% at midpoint.

• Q4 gross margin is expected to be similar to or slightly below Q3; operating expenses are expected to be similar to Q3 overall.

• Cash flow from operations breakeven is now expected in H2 2027, later than the original plan to reach breakeven entering 2027.

• 2027 revenue growth is expected to accelerate versus 2026, with investment in topline growth, operating-model improvements and profitability.